FDA details medical devices approved through de novo fast-track
August 20, 2012 by MassDevice staff
The FDA updates its list of medical devices approved through the de novo review pathway, reserved for medical devices that are novel but represent low risks to patients.
The FDA updated its reporting on its newly streamlined de novo medical device review pathway, detailing products the agency has cleared so far.
The update includes approval letters and decision summaries that the agency hopes may serve as a resource for other device makers hoping to submit devices for de novo review.
- Show paged
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
Devon Medical gains extriCARE CE Mark
Devon Medical wins CE Mark approval in the European Union for its portable extriCARE negative...
Prosthetics makers sue Medicare over payment rules
The American Orthotic and Prosthetic Assn. sues Medicare and the U.S. Health & Human Services...
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on-metal implants
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
